These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27267514)

  • 1. Effect of Transplant on Platelet Function Markers (P-Selectin and Platelet Aggregation) and Adiponectin in Renal Transplant Patients.
    Sahin G; Temiz G; Ozkurt S; Bal C; Bozaci I; Bayrak Torun C; Akay OM; Uslu S; Yalcin AU; Gulbas Z; Kiper H
    Exp Clin Transplant; 2018 Apr; 16(2):160-165. PubMed ID: 27267514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between endothelial and platelet function markers and adiponectin in renal transplanted recipients on cyclosporine and tacrolimus immunosuppression based therapy.
    Sahin G; Akay OM; Uslu S; Bal C; Yalcin AU; Gulbas Z
    Nephrology (Carlton); 2015 Jun; 20(6):392-8. PubMed ID: 25650527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of immunosuppressive drugs on platelet aggregation and soluble P-selectin levels in renal transplant patients.
    Sahin G; Akay OM; Kus E; Bal C; Yalcin AU; Gulbas Z
    Ren Fail; 2009; 31(2):111-7. PubMed ID: 19212907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Hyperparathyroid State on Platelet Functions and Bone Loss.
    Yorulmaz G; Akalın A; Akay OM; Şahin G; Bal C
    Turk J Haematol; 2016 Dec; 33(4):293-298. PubMed ID: 26377856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients.
    Sahin G; Akay OM; Bal C; Yalcin AU; Gulbas Z
    Clin Nephrol; 2011 Sep; 76(3):218-25. PubMed ID: 21888859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal adiponectin levels in kidney transplant patients with hypertension.
    Leibowitz A; Peleg E; Ben-David A; Sharabi Y; Kamari Y; Holzman E; Grossman E
    Clin Transplant; 2013; 27(4):562-6. PubMed ID: 23758483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome.
    Restituto P; Colina I; Varo JJ; Varo N
    Am J Physiol Endocrinol Metab; 2010 May; 298(5):E1072-7. PubMed ID: 20197504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of platelet activity before and after cessation of clopidogrel therapy in patients with stable cardiovascular disease.
    Ford I; Scott NW; Herd V; Mitchell LR; Williams DJ; Brittenden J
    J Am Coll Cardiol; 2014 Jan; 63(3):233-9. PubMed ID: 24211510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet function alterations and their relation to P-selectin (CD62P) expression in children with iron deficiency anemia.
    Yıldırım ZK; Orhan MF; Büyükavcı M
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):98-101. PubMed ID: 21245745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomised controlled trial.
    Spiel AO; Bartko J; Schwameis M; Firbas C; Siller-Matula J; Schuetz M; Weigl M; Jilma B
    Thromb Haemost; 2011 Apr; 105(4):655-62. PubMed ID: 21301783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of platelet aggregation function of apheresis collected platelets and soluble P-selectin during storage].
    Xie ZT; Yang LH; Tao ZH; Wang MS; Hong JY; Zhou W; Chen ZQ; Dai MJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1188-91. PubMed ID: 18928625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study.
    Kaisar MO; Armstrong K; Hawley C; Campbell S; Mudge D; Johnson DW; Prins JB; Isbel NM
    BMC Nephrol; 2009 Oct; 10():29. PubMed ID: 19821969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the data.
    Sharma G; Berger JS
    J Thromb Thrombolysis; 2011 Aug; 32(2):201-8. PubMed ID: 21562837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients.
    Bayés B; Granada ML; Lauzurica R; Pastor MC; Navarro M; Bonet J; Llopis MA; Romero R
    Transplant Proc; 2005 Nov; 37(9):3808-12. PubMed ID: 16386546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets.
    Würtz M; Grove EL; Wulff LN; Kaltoft AK; Tilsted HH; Jensen LO; Hvas AM; Kristensen SD
    JACC Cardiovasc Interv; 2010 Aug; 3(8):828-35. PubMed ID: 20723855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is enhanced platelet activation the missing link leading to increased cardiovascular risk in psoriasis?
    Chandrashekar L; Rajappa M; Revathy G; Sundar I; Munisamy M; Ananthanarayanan PH; Thappa DM; Basu D
    Clin Chim Acta; 2015 Jun; 446():181-5. PubMed ID: 25920693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in platelet morphology and function during 24 hours of storage.
    Braune S; Walter M; Schulze F; Lendlein A; Jung F
    Clin Hemorheol Microcirc; 2014; 58(1):159-70. PubMed ID: 25227196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of eltrombopag-induced platelets compared to platelets from control patients with immune thrombocytopenia.
    Haselboeck J; Kaider A; Pabinger I; Panzer S
    Thromb Haemost; 2013 Apr; 109(4):676-83. PubMed ID: 23389750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.